Description

Asymmetric dimethylarginine-d7 (hydrochloride hydrate) is the deuterium labeled Asymmetric dimethylarginine. Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS), and functions as a marker of endothelial dysfunction in a num–Applications-Cancer-programmed cell death-Formula-N/A-Citation–References-[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Hudson CL, et al. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression. Ann Clin Biochem. 2014 Sep;51(Pt 5):568-75.-CASNumber–MolecularWeight-N/A-Compound Purity–SMILES-CN(C)C(NC([2H])([2H])C([2H])([2H])C([2H])([2H])C(N)([2H])C(O)=O)=N.Cl.[xH2O]-Research_Area-Cardiovascular Disease; Cancer-Solubility-10 mM in DMSO-Target-Endogenous Metabolite;Isotope-Labeled Compounds;NO Synthase-Isoform–Pathway-Immunology/Inflammation;Metabolic Enzyme/Protease;Others-MCE Product type-Isotope-Labeled Compounds